Results 141 to 150 of about 116,704 (219)

Microwave-Assisted Preparation of Coffee-Based Activated Carbons: Characteristics, Properties, and Potential Application as Adsorbents for Water Purification. [PDF]

Molecules
Pączkowski P, Kyshkarova V, Nikolenko V, Arkhipenko O, Melnyk I, Gawdzik B.   +5 more
europepmc   +1 more source

Precision Treatment of Pulmonary Sarcoma Metastasis Using Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy: A Case Report. [PDF]

Cureus
Stergioula A, Kormas T, Kokkali S, Kyriazoglou A, Pantelis E.   +4 more
europepmc   +1 more source

Reassessing high-dose ranibizumab in the era of durable anti-VEGF therapy. [PDF]

Front Ophthalmol (Lausanne)
Cheng CK, Tsai CJ, Bai CH.
europepmc   +1 more source

Ultra-high-energy γ-ray emission associated with the tail of a bow-shock pulsar wind nebula. [PDF]

Innovation (Camb)
LHAASO Collaborationxurenfeng@ihep.ac.cnk-wang@smail.nju.edu.cnchensz@ihep.ac.cnryliu@nju.edu.cnxisq@ihep.ac.cnhushicong@ihep.ac.cn.
europepmc   +1 more source

Salvage of undeflatable intra-stent angioplasty-balloon-catheter with direct percutaneous needle puncture. [PDF]

CVIR Endovasc
Pasquetti L, Pasqui E, Galzerano G, Lazzeri E, Gargiulo B, de Donato G.   +5 more
europepmc   +1 more source

The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular Degeneration. [PDF]

Ophthalmol Ther
Bhatia B, Sim SY, Chalkiadaki E, Koutsocheras G, Nicholson L, Selvam S, Sivaprasad S, Pal B, Huemer J, Keane PA, Hamilton R, Patel PJ, Moorfields Medical Retina Injection Service.   +12 more
europepmc   +1 more source

Diagnosis of early glaucoma likely combined with high myopia by integrating OCT thickness map and standard automated and Pulsar perimetries. [PDF]

Sci Rep
Yang AS, Wang HS, Li TJ, Liu CH, Chen CM.   +4 more
europepmc   +1 more source

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol. [PDF]

BMC Cancer
Courtney PT, L Santoso M, Savjani RR, K Reddy V, Chai-Ho W, Velez Velez MA, J Wong D, Palodichuk C, Basehart TV, P O'Connell D, Cao M, Telesca D, Chin RK.   +12 more
europepmc   +1 more source

Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration. [PDF]

Ther Adv Ophthalmol
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Sun X, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Wong TY.   +20 more
europepmc   +1 more source

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies. [PDF]

Eur Respir J
Hoeper MM, Gomberg-Maitland M, Badesch DB, Gibbs JSR, Grünig E, Kopeć G, McLaughlin VV, Meyer G, Olsson KM, Preston IR, Rosenkranz S, Souza R, Waxman AB, Perchenet L, Strait J, Xing A, Manimaran S, Wang X, Miller B, Cornell AG, de Oliveira Pena J, Ghofrani HA, Humbert M.   +22 more
europepmc   +1 more source